Skip to content
Screener

Tandem Diabetes Care TNDM Total Liabilities & Equity

Total Liabilities & Equity at other companies

Insulet logo
InsuletPODD
$3.17B-8.8%
Medtronic logo
MedtronicMDT
$93.03B+1.5%
Beta Bionics logo
Beta BionicsBBNX
$292.39M-11.4%
Embecta Corp. logo
Embecta Corp.EMBC
$1.27B+9.3%
AdaptHealth logo
AdaptHealthAHCO
$4.42B-0.3%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$98.66M-5.4%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.56B+128%
Enterprise value$2.23B+109%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
AssetsJune 30, 2026 / (Unaudited)December 31, 2025 / (Note 1)
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.001 par value; 200,000 shares authorized, 69,540 and 68,291 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively7068
Additional paid-in capital1,418,0111,402,044
Accumulated other comprehensive income6,4035,593
Accumulated deficit(1,294,096)(1,252,535)
Total stockholders’ equity130,388155,170
Total liabilities and stockholders’ equity$1,154,202$881,112

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's total liabilities & equity?
Tandem Diabetes Care (TNDM) reported total liabilities & equity of $1.15B in Q2 2026.
How has Tandem Diabetes Care's total liabilities & equity changed year-over-year?
Tandem Diabetes Care's total liabilities & equity increased by 31.8% year-over-year, from $875.74M to $1.15B.
What is the long-term trend for Tandem Diabetes Care's total liabilities & equity?
Over 5 years (2020 to 2025), Tandem Diabetes Care's total liabilities & equity has grown at a 4.2% compound annual growth rate (CAGR), from $716.42M to $881.11M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Tandem Diabetes Care's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude